Previous 10 | Next 10 |
Gainers: Biofrontera (NASDAQ:BFRI) +14%. Synaptogenix (NASDAQ:SNPX) +11%. IceCure Medical (NASDAQ:ICCM) +10%. Immunic (NASDAQ:IMUX) +10%. Oncternal Therapeutics (NASDAQ:ONCT) +10%. Losers: Sio Gene Therapies (NASDAQ:SIOX) -19%. Anavex Life Sciences (NASDAQ:A...
IceCure Medical Announces Preliminary Unaudited 2021 Year-End Financial Results Revenue increase driven by sales through distribution agreements for IceCure's groundbreaking minimally-invasive cryoablation tumor destruction technology. Robust balance sheet supports global ro...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s time to dive into another day of investing with the biggest pre-market stock movers for Thursday! Source: f11photo/Shutterstock.com Moving stocks this morning are FDA updates, merge...
IceCure Medical CEO Issues Letter to Shareholders PR Newswire CAESAREA, Israel , Jan. 5, 2022 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSens...
Gainers: Microbot Medical (NASDAQ:MBOT) +51%, CollPlant Biotechnologies (NASDAQ:CLGN) +27%, Lucira Health (NASDAQ:LHDX) +14%, IceCure Medical (NASDAQ:ICCM) +13%, Cue Health (NASDAQ:HLTH) +12%. Losers: BridgeBio Pharma (NASDAQ:BBIO) -71%, Biond...
IceCure Medical Receives Notice of Intention to Grant a European Patent Covering Its Cryogenic Pump PR Newswire CAESAREA, Israel , Dec. 20, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minima...
IceCure Medical (ICCM -11.1%) trades 10% higher premarket on announcing the closing of its underwritten public offering of 3.89M shares of the Co.'s ordinary shares, inclusive of 0.58M shares offered pursuant to the underwriters' over-allotment option, at a price to the public ...
Galera Therapeutics (NASDAQ:GRTX) +138% announces primary endpoint met statistical significance in corrected topline efficacy data of phase 3 ROMAN trial of avasopasem. Nuverra Environmental Solutions (NYSE:NES) +33%. Terminix Global Holdings (NYSE:TMX) +25%. MIND Technology (NASDAQ:MIND...
IceCure Medical Ltd. Closes $17 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option PR Newswire CAESAREA, Israel , Dec. 13, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (the " Company " or " IceCur...
Gainers: Inspira Technologies (NASDAQ:IINN) +92%. Ensysce Biosciences (NASDAQ:ENSC) +79%. Insignia (NASDAQ:ISIG) +44%. Hovnanian Enterprises (NASDAQ:HOVNP) +33%. American Virtual Cloud Technologies (NASDAQ:AVCT) +31%. Blue Star Foods Corp. (NASDAQ:BSFC) +16%. Hovnanian (NYSE:HO...
News, Short Squeeze, Breakout and More Instantly...
99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society PR Newswire Demand for minimally invasive breast cancer treatment was ove...
European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment fo...
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...